Company / Total Assets
BIOCRYST PHARMACEUTICALS INC Total Assets History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Total Assets
$514.2M
FY2025
5-year range
$490.4M / $588.2M
FY2021-FY2025
Trend
+4.8%
vs FY2024
Sector context
#134 of 214
Health Care
What the data says
At $514M, BIOCRYST PHARMACEUTICALS INC's total assets ranks #134 of 214 in the Health Care sector. Total Assets returned to growth in FY2025 after 3 years of decline, reaching $514M.
Based on SEC 10-K filings.
$514M in FY2025 with a 5-year CAGR of +9.0%.
Remained stable around $514M over the past 2 years.
Health Care sector context is included.
Total Assets over time
Growth rates
- 3-Year CAGR
- -2.2%
- 5-Year CAGR
- +9.0%
- 10-Year CAGR
- -
Sector benchmark
#134 of 214 in Health CareTop 63% of 214This company $514.2M Sector average $7.5B
▼
-93.1% below sector average
Key checks
Key Insights
- 5-year CAGR of +9.0%, indicating consistent growth.
- In FY2025, total assets increased 4.8% year-over-year.
- Ranks #134 out of 214 companies in the Health Care sector.
- Peak total assets was recorded in FY2021.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Total AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $514.2M | +4.8% |
| FY2024 | $490.4M | -5.1% |
| FY2023 | $517.0M | -6.0% |
| FY2022 | $550.0M | -6.5% |
| FY2021 | $588.2M | +75.7% |
| FY2020 | $334.7M | +91.0% |
| FY2019 | $175.3M | +19.4% |
| FY2018 | $146.8M | -17.6% |
| FY2017 | $178.3M | +98.4% |
| FY2016 | $89.8M | -26.6% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026